Topic evidence map

BPC-157, TB-500, KPV, MOTS-c, GHK-Cu, Semax, Epitalon, CJC-1295, Ipamorelin, Sermorelin and the messy line between approved medicine, compounding and research chemicals.

Rapamycin, metformin, acarbose, GLP-1s, SGLT2 inhibitors and other drugs discussed as geroprotectors.

NMN, NR, NAD IV, urolithin A, taurine, creatine, CoQ10, spermidine, resveratrol, berberine and mitochondrial health claims.

CRISPR, FDA-approved gene therapies, partial epigenetic reprogramming, OSK factors, ER-100, telomerase and the frontier of cellular rejuvenation.

Epigenetic clocks, biological age tests, VO2 max, DEXA, CGM, ApoB, Lp(a), HRV, blood panels and quantified-self measurement.

Senescent cells, senolytics, fisetin, quercetin, dasatinib, inflammation, immune aging and the hallmarks of aging.

Exercise, sleep, sauna, cold exposure, fasting, protein, strength training, zone 2, VO2 max and recovery basics.

FDA status, compounding, off-label use, supplement claims, longevity clinics, med spas, advertising claims, source quality and patient safety.